Cargando…

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections

INTRODUCTION: Measurement of prohormones representing different pathophysiological pathways could enhance risk stratification in patients with community-acquired pneumonia (CAP) and other lower respiratory tract infections (LRTI). METHODS: We assessed clinical parameters and five biomarkers, the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuetz, Philipp, Wolbers, Marcel, Christ-Crain, Mirjam, Thomann, Robert, Falconnier, Claudine, Widmer, Isabelle, Neidert, Stefanie, Fricker, Thomas, Blum, Claudine, Schild, Ursula, Morgenthaler, Nils G, Schoenenberger, Ronald, Henzen, Christoph, Bregenzer, Thomas, Hoess, Claus, Krause, Martin, Bucher, Heiner C, Zimmerli, Werner, Mueller, Beat
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911752/
https://www.ncbi.nlm.nih.gov/pubmed/20529344
http://dx.doi.org/10.1186/cc9055
_version_ 1782184512438927360
author Schuetz, Philipp
Wolbers, Marcel
Christ-Crain, Mirjam
Thomann, Robert
Falconnier, Claudine
Widmer, Isabelle
Neidert, Stefanie
Fricker, Thomas
Blum, Claudine
Schild, Ursula
Morgenthaler, Nils G
Schoenenberger, Ronald
Henzen, Christoph
Bregenzer, Thomas
Hoess, Claus
Krause, Martin
Bucher, Heiner C
Zimmerli, Werner
Mueller, Beat
author_facet Schuetz, Philipp
Wolbers, Marcel
Christ-Crain, Mirjam
Thomann, Robert
Falconnier, Claudine
Widmer, Isabelle
Neidert, Stefanie
Fricker, Thomas
Blum, Claudine
Schild, Ursula
Morgenthaler, Nils G
Schoenenberger, Ronald
Henzen, Christoph
Bregenzer, Thomas
Hoess, Claus
Krause, Martin
Bucher, Heiner C
Zimmerli, Werner
Mueller, Beat
author_sort Schuetz, Philipp
collection PubMed
description INTRODUCTION: Measurement of prohormones representing different pathophysiological pathways could enhance risk stratification in patients with community-acquired pneumonia (CAP) and other lower respiratory tract infections (LRTI). METHODS: We assessed clinical parameters and five biomarkers, the precursor levels of adrenomedullin (ADM), endothelin-1 (ET1), atrial-natriuretic peptide (ANP), anti-diuretic hormone (copeptin), and procalcitonin in patients with LRTI and CAP enrolled in the multicenter ProHOSP study. We compared the prognostic accuracy of these biomarkers with the pneumonia severity index (PSI) and CURB65 (Confusion, Urea, Respiratory rate, Blood pressure, Age 65) score to predict serious complications defined as death, ICU admission and disease-specific complications using receiver operating curves (ROC) and reclassification methods. RESULTS: During the 30 days of follow-up, 134 serious complications occurred in 925 (14.5%) patients with CAP. Both PSI and CURB65 overestimated the observed mortality (X(2 )goodness of fit test: P = 0.003 and 0.01). ProADM or proET1 alone had stronger discriminatory powers than the PSI or CURB65 score or any of either score components to predict serious complications. Adding proADM alone (or all five biomarkers jointly) to the PSI and CURB65 scores, significantly increased the area under the curve (AUC) for PSI from 0.69 to 0.75, and for CURB65 from 0.66 to 0.73 (P < 0.001, for both scores). Reclassification methods also established highly significant improvement (P < 0.001) for models with biomarkers if clinical covariates were more flexibly adjusted for. The developed prediction models with biomarkers extrapolated well if evaluated in 434 patients with non-CAP LRTIs. CONCLUSIONS: Five biomarkers from distinct biologic pathways were strong and specific predictors for short-term adverse outcome and improved clinical risk scores in CAP and non-pneumonic LRTI. Intervention studies are warranted to show whether an improved risk prognostication with biomarkers translates into a better clinical management and superior allocation of health care resources. TRIAL REGISTRATION: NCT00350987.
format Text
id pubmed-2911752
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29117522010-07-29 Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections Schuetz, Philipp Wolbers, Marcel Christ-Crain, Mirjam Thomann, Robert Falconnier, Claudine Widmer, Isabelle Neidert, Stefanie Fricker, Thomas Blum, Claudine Schild, Ursula Morgenthaler, Nils G Schoenenberger, Ronald Henzen, Christoph Bregenzer, Thomas Hoess, Claus Krause, Martin Bucher, Heiner C Zimmerli, Werner Mueller, Beat Crit Care Research INTRODUCTION: Measurement of prohormones representing different pathophysiological pathways could enhance risk stratification in patients with community-acquired pneumonia (CAP) and other lower respiratory tract infections (LRTI). METHODS: We assessed clinical parameters and five biomarkers, the precursor levels of adrenomedullin (ADM), endothelin-1 (ET1), atrial-natriuretic peptide (ANP), anti-diuretic hormone (copeptin), and procalcitonin in patients with LRTI and CAP enrolled in the multicenter ProHOSP study. We compared the prognostic accuracy of these biomarkers with the pneumonia severity index (PSI) and CURB65 (Confusion, Urea, Respiratory rate, Blood pressure, Age 65) score to predict serious complications defined as death, ICU admission and disease-specific complications using receiver operating curves (ROC) and reclassification methods. RESULTS: During the 30 days of follow-up, 134 serious complications occurred in 925 (14.5%) patients with CAP. Both PSI and CURB65 overestimated the observed mortality (X(2 )goodness of fit test: P = 0.003 and 0.01). ProADM or proET1 alone had stronger discriminatory powers than the PSI or CURB65 score or any of either score components to predict serious complications. Adding proADM alone (or all five biomarkers jointly) to the PSI and CURB65 scores, significantly increased the area under the curve (AUC) for PSI from 0.69 to 0.75, and for CURB65 from 0.66 to 0.73 (P < 0.001, for both scores). Reclassification methods also established highly significant improvement (P < 0.001) for models with biomarkers if clinical covariates were more flexibly adjusted for. The developed prediction models with biomarkers extrapolated well if evaluated in 434 patients with non-CAP LRTIs. CONCLUSIONS: Five biomarkers from distinct biologic pathways were strong and specific predictors for short-term adverse outcome and improved clinical risk scores in CAP and non-pneumonic LRTI. Intervention studies are warranted to show whether an improved risk prognostication with biomarkers translates into a better clinical management and superior allocation of health care resources. TRIAL REGISTRATION: NCT00350987. BioMed Central 2010 2010-06-08 /pmc/articles/PMC2911752/ /pubmed/20529344 http://dx.doi.org/10.1186/cc9055 Text en Copyright ©2010 Schuetz et al.; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Schuetz, Philipp
Wolbers, Marcel
Christ-Crain, Mirjam
Thomann, Robert
Falconnier, Claudine
Widmer, Isabelle
Neidert, Stefanie
Fricker, Thomas
Blum, Claudine
Schild, Ursula
Morgenthaler, Nils G
Schoenenberger, Ronald
Henzen, Christoph
Bregenzer, Thomas
Hoess, Claus
Krause, Martin
Bucher, Heiner C
Zimmerli, Werner
Mueller, Beat
Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
title Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
title_full Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
title_fullStr Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
title_full_unstemmed Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
title_short Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
title_sort prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911752/
https://www.ncbi.nlm.nih.gov/pubmed/20529344
http://dx.doi.org/10.1186/cc9055
work_keys_str_mv AT schuetzphilipp prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT wolbersmarcel prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT christcrainmirjam prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT thomannrobert prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT falconnierclaudine prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT widmerisabelle prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT neidertstefanie prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT frickerthomas prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT blumclaudine prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT schildursula prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT morgenthalernilsg prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT schoenenbergerronald prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT henzenchristoph prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT bregenzerthomas prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT hoessclaus prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT krausemartin prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT bucherheinerc prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT zimmerliwerner prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections
AT muellerbeat prohormonesforpredictionofadversemedicaloutcomeincommunityacquiredpneumoniaandlowerrespiratorytractinfections